Cargando…
Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis
BACKGROUND: IgA nephropathy is the most common progressive glomerular disease to end stage renal failure worldwide. Calcineurin inhibitors (CNIs) is a selective immunosuppressant widely used in organ transplantation. The efficacy and safety of calcineurin inhibitors for the treatment of IgA nephropa...
Autores principales: | Song, Yu-Huan, Cai, Guang-Yan, Xiao, Yue-Fei, Wang, Yi-Ping, Yuan, Bao-Shi, Xia, Yuan-Yuan, Wang, Si-Yang, Chen, Pu, Liu, Shu-Wen, Chen, Xiang-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307812/ https://www.ncbi.nlm.nih.gov/pubmed/28193247 http://dx.doi.org/10.1186/s12882-017-0467-z |
Ejemplares similares
-
Nomogram prediction model for renal anaemia in IgA nephropathy patients
por: Li, Fei, et al.
Publicado: (2021) -
The effect of calcineurin inhibitors in the treatment of IgA nephropathy: A systematic review and meta-analysis (PRISMA)
por: Peng, Wei, et al.
Publicado: (2016) -
Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017) -
Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019) -
Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2016)